Cardiology Flashcards

1
Q

Pulse

A

โ˜…Character of the pulse Determined by
1. Stroke volume
2. Arterial compliance

โ˜… Pulse is best assessed in
Major arteries such as radial and Carotid

โ˜… Bounding pulse
+AR
+Anaemina
+Sepsis

โ˜… Slow rising pulse
+AS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

JVP

A

โ˜… Height of the JVP is determined by right atrial pressure
+ elevated in rt atrial pressure
+ reduced in hypovolemia

โ˜… a wave - atrial systole
+ Absent: AF
+ Giant:
โˆšTS
โˆšPS
โˆš Pulmonary hypertension
โˆš Right heart failure
+ Irregular canon โ€˜aโ€™ wave: 3ยฐ heart block
+ regular canon โ€˜aโ€™ wave:
โˆš VT

โ˜… v waves- ventricular systole
+ Giant v wave : TR

โ˜… x descent - atrial relaxation & apical displacement of tricuspid valve ring

โ˜… y descent - atrial emptying early in diastole
+Prominent & deep y descent: constrictive pericarditis
+Absent or slow Y descent: Cardiac tamponade

โ˜…Paradoxical JVP
+ Constructive pericarditis
+ Cardiac tamponade
+ Pericardial effusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Annulus Fibrosus

A

โ˜… Separate atria and ventricles
โ˜… Forms the skeleton for AV valves
โ˜… Electrically insulate atria and ventricle / Forms a conduction barrier between atria and ventricle
โ˜… Prevent conduction of transmission except av node

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cardiac Silhouette

A

On left is formed by
โ˜… aortic arch
โ˜… pulmonary trunk
โ˜… left atrial appendage
โ˜… LV

On right
โ˜… RA
โ˜… RV
โ˜… Superior and inferior vena cava

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

๐—–๐—ผ๐—ฟ๐—ผ๐—ป๐—ฎ๐—ฟ๐˜† ๐—ฐ๐—ถ๐—ฟ๐—ฐ๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป

A

๐—–๐—ผ๐—ฟ๐—ผ๐—ป๐—ฎ๐—ฟ๐˜† ๐—ฐ๐—ถ๐—ฟ๐—ฐ๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป
Lt main coronary artery
+ LAD :
โœ“ ๐—”๐—ป๐˜๐—ฒ๐—ฟ๐—ถ๐—ผ๐—ฟ ๐—ถ๐—ป๐˜๐—ฒ๐—ฟ๐˜ƒ๐—ฒ๐—ป๐˜๐—ฟ๐—ถ๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐—ด๐—ฟ๐—ผ๐—ผ๐˜ƒ๐—ฒ
โœ“ ๐—ฆ๐˜‚๐—ฝ๐—ฝ๐—น๐—ถ๐—ฒ๐˜€ ๐—ฎ๐—ป๐˜๐—ฒ๐—ฟ๐—ถ๐—ผ๐—ฟ ๐—ฝ๐—ฎ๐—ฟ๐˜ ๐—ผ๐—ณ ๐˜€๐—ฒ๐—ฝ๐˜๐˜‚๐—บ & ๐—ฎ๐—ป๐˜๐—ฒ๐—ฟ๐—ถ๐—ผ๐—ฟ, ๐—น๐—ฎ๐˜๐—ฒ๐—ฟ๐—ฎ๐—น & ๐—ฎ๐—ฝ๐—ถ๐—ฐ๐—ฎ๐—น ๐˜„๐—ฎ๐—น๐—น๐˜€ ๐—ผ๐—ณ ๐—Ÿ๐—ฉ
+ Lt circumflex artery :
โœ“ ๐—ฃ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ๐—ถ๐—ผ๐—ฟ๐—น๐˜† ๐—ถ๐—ป ๐—”๐—ฉ ๐—ด๐—ฟ๐—ผ๐—ผ๐˜ƒ๐—ฒ
โœ“ ๐—ฆ๐˜‚๐—ฝ๐—ฝ๐—น๐—ถ๐—ฒ๐˜€ ๐—น๐—ฎ๐˜๐—ฒ๐—ฟ๐—ฎ๐—น, ๐—ฝ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ๐—ถ๐—ผ๐—ฟ & ๐—ถ๐—ป๐—ณ๐—ฒ๐—ฟ๐—ถ๐—ผ๐—ฟ ๐˜€๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—ผ๐—ณ ๐—Ÿ๐—ฉ
*** ๐™Š๐™˜๐™˜๐™ก๐™ช๐™จ๐™ž๐™ค๐™ฃ ๐™ค๐™› ๐™ก๐™š๐™›๐™ฉ ๐™ข๐™–๐™ž๐™ฃ ๐™˜๐™ค๐™ง๐™ค๐™ฃ๐™–๐™ง๐™ฎ ๐™–๐™ง๐™ฉ๐™š๐™ง๐™ฎ ๐™ž๐™จ ๐™ช๐™จ๐™ช๐™–๐™ก๐™ก๐™ฎ ๐™›๐™–๐™ฉ๐™–๐™ก
Right coronary artery
+ ๐—ฅ๐˜‚๐—ป๐˜€ ๐—ถ๐—ป ๐—ฟ๐—ถ๐—ด๐—ต๐˜ ๐—”๐—ฉ ๐—ด๐—ฟ๐—ผ๐—ผ๐˜ƒ๐—ฒ
+ ๐—ฆ๐˜‚๐—ฝ๐—ฝ๐—น๐—ถ๐—ฒ๐˜€ ๐—ฅ๐—”, ๐—ฅ๐—ฉ & ๐—ถ๐—ป๐—ณ๐—ฒ๐—ฟ๐—ผ๐—ฝ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ๐—ถ๐—ผ๐—ฟ ๐—ฎ๐˜€๐—ฝ๐—ฒ๐—ฐ๐˜๐˜€ ๐—ผ๐—ณ ๐—Ÿ๐—ฉ, ๐—ฆ๐—” ๐—ป๐—ผ๐—ฑ๐—ฒ (๐Ÿฒ๐Ÿฌ%) & ๐—”๐—ฉ ( ๐Ÿต๐Ÿฌ%)
+ ๐™‹๐™ง๐™ค๐™ญ๐™ž๐™ข๐™–๐™ก ๐™ค๐™˜๐™˜๐™ก๐™ช๐™จ๐™ž๐™ค๐™ฃ ๐™ค๐™› ๐™๐˜พ๐˜ผ ๐™ฉ๐™๐™š๐™ง๐™š๐™›๐™ค๐™ง๐™š ๐™ค๐™›๐™ฉ๐™š๐™ฃ ๐™ง๐™š๐™จ๐™ช๐™ก๐™ฉ๐™จ ๐™ž๐™ฃ ๐™จ๐™ž๐™ฃ๐™ช๐™จ ๐™—๐™ง๐™–๐™™๐™ฎ๐™˜๐™–๐™ง๐™™๐™ž๐™– & ๐˜ผ๐™‘ ๐™ฃ๐™ค๐™™๐™–๐™ก ๐™—๐™ก๐™ค๐™˜๐™ .

*** Posterior descending artery
+ ๐—ฅ๐˜‚๐—ป๐˜€ ๐—ถ๐—ป ๐—ฝ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ๐—ถ๐—ผ๐—ฟ ๐—ถ๐—ป๐˜๐—ฒ๐—ฟ๐˜ƒ๐—ฒ๐—ป๐˜๐—ฟ๐—ถ๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐—ด๐—ฟ๐—ผ๐—ผ๐˜ƒ๐—ฒ
+ ๐—ฆ๐˜‚๐—ฝ๐—ฝ๐—น๐—ถ๐—ฒ๐˜€ ๐—ถ๐—ป๐—ณ๐—ฒ๐—ฟ๐—ถ๐—ผ๐—ฟ ๐—ฝ๐—ฎ๐—ฟ๐˜ ๐—ผ๐—ณ ๐—ถ๐—ป๐˜๐—ฒ๐—ฟ๐˜ƒ๐—ฒ๐—ป๐˜๐—ฟ๐—ถ๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐˜€๐—ฒ๐—ฝ๐˜๐˜‚๐—บ
+ ๐—ง๐—ต๐—ถ๐˜€ ๐—ถ๐˜€ ๐—ฎ ๐—ฏ๐—ฟ๐—ฎ๐—ป๐—ฐ๐—ต ๐—ผ๐—ณ ๐—ฅ๐—–๐—” ๐—ถ๐—ป ๐—ฎ๐—ฝ๐—ฝ๐—ฟ๐—ผ๐˜…๐—ถ๐—บ๐—ฎ๐˜๐—ฒ๐—น๐˜† ๐Ÿต๐Ÿฌ% ๐—ผ๐—ณ ๐—ฝ๐—ฒ๐—ผ๐—ฝ๐—น๐—ฒ (dominant right system) & is
supplied by CX in the remainder (dominant left system).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Depolarization starts in?

A

SA node
- Situated at the junction of SVC and RA
- Rate is Influenced by ANS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nerve Supply of heart

A
  • Effects of sympathetic activity
    + ฮฒ๐Ÿญ-๐—ฎ๐—ฑ๐—ฟ๐—ฒ๐—ป๐—ผ๐—ฐ๐—ฒ๐—ฝ๐˜๐—ผ๐—ฟ๐˜€ ๐—ถ๐—ป ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜ ๐—ฟ๐—ฒ๐˜€๐˜‚๐—น๐˜๐˜€: ๐—ฃ๐—ผ๐˜€๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ถ๐—ป๐—ผ๐˜๐—ฟ๐—ผ๐—ฝ๐—ถ๐—ฐ & ๐—ฐ๐—ต๐—ฟ๐—ผ๐—ป๐—ผ๐˜๐—ฟ๐—ผ๐—ฝ๐—ถ๐—ฐ ๐—ฒ๐—ณ๐—ณ๐—ฒ๐—ฐ๐˜๐˜€,
    + ฮฒ๐Ÿฎ-๐—ฎ๐—ฑ๐—ฟ๐—ฒ๐—ป๐—ผ๐—ฐ๐—ฒ๐—ฝ๐˜๐—ผ๐—ฟ๐˜€ ๐—ถ๐—ป ๐˜ƒ๐—ฎ๐˜€๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐˜€๐—บ๐—ผ๐—ผ๐˜๐—ต ๐—บ๐˜‚๐˜€๐—ฐ๐—น๐—ฒ : ๐—ฉ๐—ฎ๐˜€๐—ผ๐—ฑ๐—ถ๐—น๐—ฎ๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป
  • Parasympathetic
    + Pre- Preganglionic & sensory fibers reach the heart through vagus nerves
    + Cholinergic nerves supply AV & SA nodes via muscarinic (M2) receptors
    + Under resting conditions, vagal inhibitory activity predominates & heart rate is slow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The basic unit of contraction

A

Sarcomere

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cardiac peptide

A

***ANP
+ ๐—ฉ๐—ฎ๐˜€๐—ผ๐—ฑ๐—ถ๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜€: ๐—ฅ๐—ฒ๐—ฑ๐˜‚๐—ฐ๐—ฒ ๐—ฏ๐—น๐—ผ๐—ผ๐—ฑ ๐—ฝ๐—ฟ๐—ฒ๐˜€๐˜€๐˜‚๐—ฟ๐—ฒ (๐—•๐—ฃ)
+ ๐——๐—ถ๐˜‚๐—ฟ๐—ฒ๐˜๐—ถ๐—ฐ: ๐—ฅ๐—ฒ๐—ป๐—ฎ๐—น ๐—ฒ๐˜…๐—ฐ๐—ฟ๐—ฒ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ณ ๐˜„๐—ฎ๐˜๐—ฒ๐—ฟ & ๐—ก๐—ฎ
+ ๐—ฅ๐—ฒ๐—น๐—ฒ๐—ฎ๐˜€๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—”๐˜๐—ฟ๐—ถ๐—ฎ๐—น ๐—บ๐˜†๐—ผ๐—ฐ๐˜†๐˜๐—ฒ๐˜€ in response to stretch

*** BNP
+ Produced by ๐˜ƒ๐—ฒ๐—ป๐˜๐—ฟ๐—ถ๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐—ฐ๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ผ๐—บ๐˜†๐—ผ๐—ฐ๐˜†๐˜๐—ฒ๐˜€ in response to stretch (Ex - heart failure)
+ ๐—›๐—ฎ๐˜€ ๐—ฑ๐—ถ๐˜‚๐—ฟ๐—ฒ๐˜๐—ถ๐—ฐ ๐—ฝ๐—ฟ๐—ผ๐—ฝ๐—ฒ๐—ฟ๐˜๐—ถ๐—ฒ๐˜€.

*** Neprilysin
+ ๐—˜๐—ป๐˜‡๐˜†๐—บ๐—ฒ ๐—ฝ๐—ฟ๐—ผ๐—ฑ๐˜‚๐—ฐ๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—ธ๐—ถ๐—ฑ๐—ป๐—ฒ๐˜† & ๐—ผ๐˜๐—ต๐—ฒ๐—ฟ ๐˜๐—ถ๐˜€๐˜€๐˜‚๐—ฒ๐˜€
+ ๐—•๐—ฟ๐—ฒ๐—ฎ๐—ธ๐˜€ ๐—ฑ๐—ผ๐˜„๐—ป ๐—”๐—ก๐—ฃ, ๐—•๐—ก๐—ฃ & ๐—ผ๐˜๐—ต๐—ฒ๐—ฟ ๐—ฝ๐—ฟ๐—ผ๐˜๐—ฒ๐—ถ๐—ป๐˜€
+ ๐—”๐—ฐ๐˜๐˜€ ๐—ฎ๐˜€ ๐—ฎ ๐˜ƒ๐—ฎ๐˜€๐—ผ๐—ฐ๐—ผ๐—ป๐˜€๐˜๐—ฟ๐—ถ๐—ฐ๐˜๐—ผ๐—ฟ
+ ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ฒ๐˜‚๐˜๐—ถ๐—ฐ ๐˜๐—ฎ๐—ฟ๐—ด๐—ฒ๐˜ ๐—ถ๐—ป ๐—ฝ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜๐˜€ ๐˜„๐—ถ๐˜๐—ต ๐—›๐—™

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

importance of Windkessel effect of the central artery

A

๐—ฃ๐—ฟ๐—ฒ๐˜ƒ๐—ฒ๐—ป๐˜๐˜€ ๐—ฒ๐˜…๐—ฐ๐—ฒ๐˜€๐˜€๐—ถ๐˜ƒ๐—ฒ ๐—ฟ๐—ถ๐˜€๐—ฒ๐˜€ ๐—ถ๐—ป ๐˜€๐˜†๐˜€๐˜๐—ผ๐—น๐—ถ๐—ฐ ๐—•๐—ฃ ๐˜„๐—ต๐—ถ๐—น๐—ฒ ๐˜€๐˜‚๐˜€๐˜๐—ฎ๐—ถ๐—ป๐—ถ๐—ป๐—ด ๐—ฑ๐—ถ๐—ฎ๐˜€๐˜๐—ผ๐—น๐—ถ๐—ฐ ๐—•๐—ฃ there by ๐—ฅ๐—ฒ๐—ฑ๐˜‚๐—ฐ๐—ฒ๐˜€ ๐—ฐ๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ฎ๐—ฐ ๐—ฎ๐—ณ๐˜๐—ฒ๐—ฟ๐—น๐—ผ๐—ฎ๐—ฑ & ๐—บ๐—ฎ๐—ถ๐—ป๐˜๐—ฎ๐—ถ๐—ป๐˜€ ๐—ฐ๐—ผ๐—ฟ๐—ผ๐—ป๐—ฎ๐—ฟ๐˜† ๐—ฝ๐—ฒ๐—ฟ๐—ณ๐˜‚๐˜€๐—ถ๐—ผ๐—ป

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Substances released from endothelium

A

** Substances released from endothelium
Vasodilators
+ Nitric Oxide
+ Prostacyclin
+ Endothelium-derived hyperpolarising factor
Vasoconstrictors
+ Endothelin-1
+ Angiotensin II
Von Willebrand factor (glycoprotein) : Promotes thrombus formation
Tissue plasminogen activator : Induce fibrinolysis & thrombus dissolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pulsus paradoxus

A

*** Pulsus paradoxus (exaggerated / > 10 mmHg โ†“ BP during inspiration)
+ ๐—ฆ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐—ฒ ๐—ฎ๐˜€๐˜๐—ต๐—บ๐—ฎ ๐—ผ๐—ฟ ๐—–๐—ข๐—ฃ๐——
+ ๐—–๐—ต๐—ฎ๐—ฟ๐—ฎ๐—ฐ๐˜๐—ฒ๐—ฟ๐—ถ๐˜€๐˜๐—ถ๐—ฐ ๐—ผ๐—ณ ๐—ฐ๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ฎ๐—ฐ ๐˜๐—ฎ๐—บ๐—ฝ๐—ผ๐—ป๐—ฎ๐—ฑ๐—ฒ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

P wave

A

P wave
+ ๐—”๐˜๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฑ๐—ฒ๐—ฝ๐—ผ๐—น๐—ฎ๐—ฟ๐—ถ๐˜€๐—ฎ๐˜๐—ถ๐—ผ๐—ป
+ ๐—”๐—ฏ๐˜€๐—ฒ๐—ป๐˜ : ๐—”๐˜๐—ฟ๐—ถ๐—ฎ๐—น ๐—ณ๐—ถ๐—ฏ๐—ฟ๐—ถ๐—น๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป (๐—ฆ๐—•๐—”)
+ ๐—ง๐—ฎ๐—น๐—น ๐—ฃ : ๐—ฅ๐˜ ๐—ฎ๐˜๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฒ๐—ป๐—น๐—ฎ๐—ฟ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜ (๐—ฃ ๐—ฝ๐˜‚๐—น๐—บ๐—ผ๐—ป๐—ฎ๐—น๐—ฒ)
+ ๐—ก๐—ผ๐˜๐—ฐ๐—ต๐—ฒ๐—ฑ ๐—ฃ : ๐—Ÿ๐˜ ๐—ฎ๐˜๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฒ๐—ป๐—น๐—ฎ๐—ฟ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜
(๐—ฃ ๐—บ๐—ถ๐˜๐—ฟ๐—ฎ๐—น๐—ฒ)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

PR interval

A

PR interval
+ ๐—ฅ๐—ฒ๐—ณ๐—น๐—ฒ๐—ฐ๐˜๐˜€ ๐—ฑ๐˜‚๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ณ ๐—”๐—ฉ ๐—ป๐—ผ๐—ฑ๐—ฎ๐—น ๐—ฐ๐—ผ๐—ป๐—ฑ๐˜‚๐—ฐ๐˜๐—ถ๐—ผ๐—ป
+ ๐—ฃ๐—ฟ๐—ผ๐—น๐—ผ๐—ป๐—ด๐—ฒ๐—ฑ : ๐—œ๐—บ๐—ฝ๐—ฎ๐—ถ๐—ฟ๐—ฒ๐—ฑ ๐—”๐—ฉ ๐—ป๐—ผ๐—ฑ๐—ฎ๐—น ๐—ฐ๐—ผ๐—ป๐—ฑ๐˜‚๐—ฐ๐˜๐—ถ๐—ผ๐—ป
+ ๐—ฆ๐—ต๐—ผ๐—ฟ๐˜ : ๐—ช๐—ฃ๐—ช ๐˜€๐˜†๐—ป๐—ฑ๐—ฟ๐—ผ๐—บ๐—ฒ (๐—ฆ๐—•๐—”)
+ ๐——๐—ฒ๐—ฝ๐—ฟ๐—ฒ๐˜€๐˜€๐—ถ๐—ผ๐—ป : ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ ๐—ผ๐—ณ ๐—ฎ๐—ฐ๐˜‚๐˜๐—ฒ ๐—ฝ๐—ฒ๐—ฟ๐—ถ๐—ฐ๐—ฎ๐—ฟ๐—ฑ๐—ถ๐˜๐—ถ๐˜€ (๐—ฆ๐—•๐—”)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

QRS complex

A

duration Increased : RBBB / LBBB
Increased QRS amplitude: Left ventricular hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T wave

A

T wave
+ ๐—ฉ๐—ฒ๐—ป๐˜๐—ฟ๐—ถ๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—น๐—ฎ๐—ฟ๐—ถ๐˜€๐—ฎ๐˜๐—ถ๐—ผ๐—ป
+ ๐—ง๐—ฎ๐—น๐—น, ๐—ฝ๐—ฒ๐—ฎ๐—ธ๐—ฒ๐—ฑ ๐—ง : ๐—›๐˜†๐—ฝ๐—ฒ๐—ฟ๐—ธ๐—ฎ๐—น๐—ฒ๐—บ๐—ถ๐—ฎ
+ T inversion: Ishchemia, Hypokalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ST segment

A

ST segment
+ ๐—ช๐—ถ๐—ฑ๐—ฒ๐˜€๐—ฝ๐—ฟ๐—ฒ๐—ฎ๐—ฑ ๐˜€๐—ฎ๐—ฑ๐—ฑ๐—น๐—ฒ ๐˜€๐—ฎ๐—ต๐—ฝ๐—ฒ๐—ฑ ๐—ฒ๐—น๐—ฒ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป : ๐—”๐—ฐ๐˜‚๐˜๐—ฒ ๐—ฝ๐—ฒ๐—ฟ๐—ถ๐—ฐ๐—ฎ๐—ฟ๐—ฑ๐—ถ๐˜๐—ถ๐˜€
+ ๐—ฃ๐—ฒ๐—ฟ๐˜€๐—ถ๐˜€๐˜๐—ฒ๐—ป๐˜ ๐—ฆ๐—ง ๐—ฒ๐—น๐—ฒ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป : ๐—Ÿ๐˜ ๐˜ƒ๐—ฒ๐—ป๐˜๐—ฟ๐—ถ๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐—ฎ๐—ป๐—ฒ๐˜‚๐—ฟ๐˜†๐˜€๐—บ (๐—ฆ๐—•๐—”)
+ Elevation: Ischemia
+ Depression: Ischemia or Infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

๐™‡๐™š๐™–๐™™๐™จ of ECG

A

๐™‡๐™š๐™–๐™™๐™จ
๐™‘1 & ๐™‘2&raquo_space;> ๐™๐™‘
๐™‘3 & ๐™‘4&raquo_space;> ๐™ž๐™ฃ๐™ฉ๐™š๐™ง๐™ซ๐™š๐™ฃ๐™ฉ๐™ง๐™ž๐™˜๐™ช๐™ก๐™–๐™ง ๐™จ๐™š๐™ฅ๐™ฉ๐™ช๐™ข
๐™‘5 & ๐™‘6 ๐™ค๐™ซ๐™š๐™ง &raquo_space;> ๐™‡๐™‘

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Normal Cardiac axis

A

Between -30 and +90 Degree

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Exercise ECG (positive, Contraindication)

A

considered positive if
+ Angina occurs
+ BP falls or fails to increase or
+ ST segment shifts > 1 mm

๐™Ž๐™ฉ๐™ง๐™š๐™จ๐™จ ๐™ฉ๐™š๐™จ๐™ฉ๐™ž๐™ฃ๐™œ ๐™ž๐™จ ๐™˜๐™ค๐™ฃ๐™ฉ๐™ง๐™–๐™ž๐™ฃ๐™™๐™ž๐™˜๐™–๐™ฉ๐™š๐™™ ๐™ž๐™ฃ
+ ๐™–๐™˜๐™ช๐™ฉ๐™š ๐™˜๐™ค๐™ง๐™ค๐™ฃ๐™–๐™ง๐™ฎ ๐™จ๐™ฎ๐™ฃ๐™™๐™ง๐™ค๐™ข๐™š
+ ๐™™๐™š๐™˜๐™ค๐™ข๐™ฅ๐™š๐™ฃ๐™จ๐™–๐™ฉ๐™š๐™™ ๐™๐™š๐™–๐™ง๐™ฉ ๐™›๐™–๐™ž๐™ก๐™ช๐™ง๐™š
+ ๐™จ๐™š๐™ซ๐™š๐™ง๐™š ๐™๐™ฎ๐™ฅ๐™š๐™ง๐™ฉ๐™š๐™ฃ๐™จ๐™ž๐™ค๐™ฃ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

NT-proBNP

A

NT-proBNP
+ Measured in preference to BNP since it is more stable
+ Indications
โœ“ ๐——๐—ถ๐—ฎ๐—ด๐—ป๐—ผ๐˜€๐—ถ๐˜€ ๐—ผ๐—ณ ๐—Ÿ๐—ฉ ๐—ฑ๐˜†๐˜€๐—ณ๐˜‚๐—ป๐—ฐ๐˜๐—ถ๐—ผ๐—ป
โœ“ ๐—”๐˜€๐˜€๐—ฒ๐˜€๐˜€ ๐—ฝ๐—ฟ๐—ผ๐—ด๐—ป๐—ผ๐˜€๐—ถ๐˜€ & ๐—ฟ๐—ฒ๐˜€๐—ฝ๐—ผ๐—ป๐˜€๐—ฒ ๐˜๐—ผ ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜† ๐—ถ๐—ป ๐—ฝ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜๐˜€ ๐˜„๐—ถ๐˜๐—ต ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜ ๐—ณ๐—ฎ๐—ถ๐—น๐˜‚๐—ฟ๐—ฒ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the cornerstone of Dx of MI?

A

TROPONIN I
increased in
CARDIAC
* MI, Myocarditis
* Pulmonary embolism
* Pulmonary edema
* Cardiac surgery, trauma
* Tachyarrhythmia
* Aortic dissection

NON CARDIAC
* Septic shock, Stroke,SAH
* Prolonged hypotension
* ESRD
* Burn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the baseline investigation for a patient with chest pain on exertion

A
  1. CBC / FBC
  2. FBS
  3. Lipid profile
  4. TFT
  5. ECG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the first line test of choice to diagnose angina due to coronary artery disease

A

CT Coronary angiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Causes of sudden arrhythmic death

A

Coronary artery disease

  1. Myocardial Ischaemia
  2. AMI
  3. Prior myocardial infarction with myocardial scarring

Structural heart disease

  1. AS
  2. CHD
  3. Cardiomyopathy (hypertrophic, dilated, arrhythmogenic right ventricular)

Non structural heart disease

  1. Long QT Syndrome
  2. Brugada syndrome
  3. Wolff- Parkinson- White syndrome
  4. ADR (torsades de pointes)
  5. Severe electrolyte abnormality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Features of benign innocent heart murmur

A

Soft
Mid diastolic
Heard at left sternal border
No radiation
No other cardiac abnormality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

First Heart Sound

A

Timing: Onset of systole
Cause: Due to the closure of Mitral and tricuspid valve
Nature: Usually single or narrowly splitting
Loud HS: Hyperdynamic circulation (anemia, Thyrotoxicosis, Pregnancy), MS
Soft HS: HF, MR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Second Heart Sound

A

Timing: End of the systole
Cause: The closure of Aortic and Pulmonary valve
Nature: Split on inspiration, Single on expiration
Features:
Fixed wide splitting- ASD
Wide but variable splitting- RBBB
Reversed Splitting- LBBB
Loud HS: HTN, ASD without P. HTN, Hyperdynamic state
Soft HS: AS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Third Heart Sound

A

Timing: Early in diastole Just after S2
Nature: Low pitched often heard as gallop (an early sign of LVF)
Origin: From ventricular wall
Causes: Physiological: Young People, Pregnancy
Pathological Cause: HF, MR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Fourth Heart Sound

A

End of diastole Just before S1
Ventricular Origin
Low Pitch
Absent In AF
Feature of severe LVF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Systolic Click

A

Early or Mid Systole
Brief High-intensity Sound
AS, PS, Floppy mitral valve
Prosthetic Heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Opening Snap

A

Early in Diastole
Severe MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Causes of Ejection Systolic Murmur

A

Aortic Stenosis
Pulmonary Stenosis
ASD
Aortic Or Pulmonary Flow Murmur
Benign Murmur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Pan Systolic Murmur

A

Mitral Regurgitation
Tricuspid Regurgitation
VSD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Late Systolic Murmur

A

Mitral Valve Prolapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Early Diastolic Murmur

A

Aortic regurgitation
Pulmonary Regurgitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Mid Diastolic murmur

A

MS
TS
Austin flint Murmur
Mitral Or tricuspid Flow murmur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Continuous murmur

A

PDA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Most common causes of right heart failure

A

Chronic lung disease
Pulmonary embolism
Pulmonary valvular stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Biventricular heart failure occurs in

A

Dilated cardiomyopathy
Coronary heart disease affecting both ventricle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Cardiac Output is determined by

A

Preload
afterload
Myocardial contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Obstructive Cause of HF

A

Ventricular Outflow obstruction:
HTN, AS - LHF
P. HTN , PS - RHF

Ventricular Inflow Obstruction:
MS, TS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

HF Due to Volume Overload

A
  1. Left ventricular volume overload: Aortic and Mitral regurgitation
  2. VSD
  3. Right ventricular volume Overload: ASD
  4. Increased Metabolic demand
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Arrhythmitic Cause of HF

A

AF
Tachycardia
CHB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

HF Due to Diastolic dysfunction

A

Constrictive Pericarditis
Restrictive Cardiomyopathy
Cardiac Tamponade
LVH and Fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

HF Due Reduced Ventricular Contractility

A

MI
Myocarditis/ Cardiomyopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Causes of High Output failure

A

Large AV shunt
Beri-beri
Anemia
Thyrotoxicosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Effect of prolonged sympathetic stimulation

A

Cardiac myocyte apoptosis
Cardiac Hypertrophy
Focal cardiac necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Clinical Presentation Of ALHF

A

๐—”๐—ฐ๐˜‚๐˜๐—ฒ ๐—น๐—ฒ๐—ณ๐˜ ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜ ๐—ณ๐—ฎ๐—ถ๐—น๐˜‚๐—ฟ๐—ฒ:
- ๐—ฃ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ป๐˜๐˜€ ๐˜„๐—ถ๐˜๐—ต ๐˜€๐˜‚๐—ฑ๐—ฑ๐—ฒ๐—ป ๐—ผ๐—ป๐˜€๐—ฒ๐˜ ๐—ผ๐—ณ ๐—ฑ๐˜†๐˜€๐—ฝ๐—ป๐—ผ๐—ฒ๐—ฎ ๐—ฎ๐˜ ๐—ฟ๐—ฒ๐˜€๐˜ ๐˜๐—ต๐—ฎ๐˜ ๐—ฟ๐—ฎ๐—ฝ๐—ถ๐—ฑ๐—น๐˜† ๐—ฝ๐—ฟ๐—ผ๐—ด๐—ฟ๐—ฒ๐˜€๐˜€๐—ฒ๐˜€ ๐˜๐—ผ ๐—ฎ๐—ฐ๐˜‚๐˜๐—ฒ
๐—ฟ๐—ฒ๐˜€๐—ฝ๐—ถ๐—ฟ๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—ฑ๐—ถ๐˜€๐˜๐—ฟ๐—ฒ๐˜€๐˜€, ๐—ผ๐—ฟ๐˜๐—ต๐—ผ๐—ฝ๐—ป๐—ผ๐—ฒ๐—ฎ & ultimately respiratory failure
- The patient appears agitated, pale & clammy
- Cool peripheries & rapid pulse
- BP: usually high because of SNS activation, but may be normal or low
- Gallop rhythm with ๐—” ๐˜๐—ต๐—ถ๐—ฟ๐—ฑ ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜ ๐˜€๐—ผ๐˜‚๐—ป๐—ฑ ๐—ต๐—ฒ๐—ฎ๐—ฟ๐—ฑ ๐—พ๐˜‚๐—ถ๐˜๐—ฒ ๐—ฒ๐—ฎ๐—ฟ๐—น๐˜† ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—ฑ๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜ ๐—ผ๐—ณ ๐—ฎ๐—ฐ๐˜‚๐˜๐—ฒ ๐—น๐—ฒ๐—ณ๐˜- ๐˜€๐—ถ๐—ฑ๐—ฒ๐—ฑ ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜ ๐—ณ๐—ฎ๐—ถ๐—น๐˜‚๐—ฟ๐—ฒ

  • ๐—” ๐—ป๐—ฒ๐˜„ ๐˜€๐˜†๐˜€๐˜๐—ผ๐—น๐—ถ๐—ฐ ๐—บ๐˜‚๐—ฟ๐—บ๐˜‚๐—ฟ ๐—บ๐—ฎ๐˜† ๐˜€๐—ถ๐—ด๐—ป๐—ถ๐—ณ๐˜†
    + ๐—”๐—ฐ๐˜‚๐˜๐—ฒ ๐—บ๐—ถ๐˜๐—ฟ๐—ฎ๐—น ๐—ฟ๐—ฒ๐—ด๐˜‚๐—ฟ๐—ด๐—ถ๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ฟ
    + ๐—ฉ๐—ฒ๐—ป๐˜๐—ฟ๐—ถ๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐˜€๐—ฒ๐—ฝ๐˜๐—ฎ๐—น ๐—ฟ๐˜‚๐—ฝ๐˜๐˜‚๐—ฟ๐—ฒ

-Chest examination may reveal
+ Crepitations at lung bases if there is pulmonary edema or
+ Crepitation throughout the lung field if severe

50
Q

Factors that may aggravate HF in Pre-existing Heart Disease

A
  1. MI
  2. Intercurrent Illness
  3. Arrhythmia
  4. Administration of a negative inotropic drug (B-blocker) or Fluid-retaining properties (NSAIDs, Glucocorticoid)
  5. Pulmonary embolism
  6. Increased metabolic Demand
  7. IV fluid overload
51
Q

C/F of Chronic heart Failure

A

๐—–๐—ต๐—ฟ๐—ผ๐—ป๐—ถ๐—ฐ ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜ ๐—ณ๐—ฎ๐—ถ๐—น๐˜‚๐—ฟ๐—ฒ
Clinical features
+ Fatigue & poor effort intolerance
+ Oliguria & uremia
+ Lt heart failure > Pulmonary edema > Dyspnoea & inspiratory crepitation over lung bases
+ Rt heart failure: High JVP with hepatic congestion & dependent peripheral edema

52
Q

C/F of LHF and RHF

A

LHF:
Raised JVP (++)
Pulmonary Oedema
Pleural Effusion
Cardiomegaly
Peripheral Oedema

RHF:
Raised JVP (++++)
Tender Hepatomegaly
Ascites
Peripheral Pitting Oedema (+++)

53
Q

Complication Of Heart Failure

A

Complications
#๐—ฅ๐—ฒ๐—ป๐—ฎ๐—น ๐—ณ๐—ฎ๐—ถ๐—น๐˜‚๐—ฟ๐—ฒ
#๐—›๐˜†๐—ฝ๐—ผ๐—ธ๐—ฎ๐—น๐—ฎ๐—ฒ๐—บ๐—ถ๐—ฎ due to
+ K losing diuretics
+ Hyperaldosteronism due to
โœ“ Activation of RAAS
โœ“ Impaired aldosterone metabolism from hepatic congestion
#๐—›๐˜†๐—ฝ๐—ฒ๐—ฟ๐—ธ๐—ฎ๐—น๐—ฒ๐—บ๐—ถ๐—ฎ due to
+ ACEi, ARB & Mineralocorticoid receptor antagonist
#๐—›๐˜†๐—ฝ๐—ผ๐—ป๐—ฎ๐˜๐—ฟ๐—ฎ๐—ฒ๐—บ๐—ถ๐—ฎ
+ ๐—™๐—ฒ๐—ฎ๐˜๐˜‚๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐˜€๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐—ฒ ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜ ๐—ณ๐—ฎ๐—ถ๐—น๐˜‚๐—ฟ๐—ฒ & ๐—ฃ๐—ผ๐—ผ๐—ฟ ๐—ฝ๐—ฟ๐—ผ๐—ด๐—ป๐—ผ๐˜€๐˜๐—ถ๐—ฐ ๐˜€๐—ถ๐—ด๐—ป (๐—ฆ๐—•๐—”)
#๐—œ๐—บ๐—ฝ๐—ฎ๐—ถ๐—ฟ๐—ฒ๐—ฑ ๐—น๐—ถ๐˜ƒ๐—ฒ๐—ฟ ๐—ณ๐˜‚๐—ป๐—ฐ๐˜๐—ถ๐—ผ๐—ป
#๐—ง๐—ต๐—ฟ๐—ผ๐—บ๐—ฏ๐—ผ๐—ฒ๐—บ๐—ฏ๐—ผ๐—น๐—ถ๐˜€๐—บ
#๐—”๐˜๐—ฟ๐—ถ๐—ฎ๐—น & ๐˜ƒ๐—ฒ๐—ป๐˜๐—ฟ๐—ถ๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐—ฎ๐—ฟ๐—ฟ๐—ต๐˜†๐˜๐—ต๐—บ๐—ถ๐—ฎ
#๐—ฆ๐˜‚๐—ฑ๐—ฑ๐—ฒ๐—ป ๐—ฑ๐—ฒ๐—ฎ๐˜๐—ต
+ ๐— ๐—ผ๐˜€๐˜ ๐—ผ๐—ณ๐˜๐—ฒ๐—ป ๐—ฑ๐˜‚๐—ฒ ๐˜๐—ผ ๐˜ƒ๐—ฒ๐—ป๐˜๐—ฟ๐—ถ๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐—ณ๐—ถ๐—ฏ๐—ฟ๐—ถ๐—น๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป (๐—ฆ๐—•๐—”)***

54
Q

CXR findings In HF

A

CXR should be performed in all cases
+ ๐—”๐—ฏ๐—ป๐—ผ๐—ฟ๐—บ๐—ฎ๐—น ๐—ฑ๐—ถ๐˜€๐˜๐—ฒ๐—ป๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ณ ๐˜‚๐—ฝ๐—ฝ๐—ฒ๐—ฟ ๐—น๐—ผ๐—ฏ๐—ฒ ๐—ฝ๐˜‚๐—น๐—บ๐—ผ๐—ป๐—ฎ๐—ฟ๐˜† ๐˜ƒ๐—ฒ๐—ถ๐—ป๐˜€
+ ๐— ๐—ผ๐—ฟ๐—ฒ ๐—ฝ๐—ฟ๐—ผ๐—บ๐—ถ๐—ป๐—ฒ๐—ป๐˜ ๐˜ƒ๐—ฎ๐˜€๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ๐—ถ๐˜๐˜† ๐—ผ๐—ณ ๐—น๐˜‚๐—ป๐—ด ๐—ณ๐—ถ๐—ฒ๐—น๐—ฑ
+ ๐——๐—ถ๐—น๐—ฎ๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ณ ๐—ฝ๐˜‚๐—น๐—บ๐—ผ๐—ป๐—ฎ๐—ฟ๐˜† ๐—ฎ๐—ฟ๐˜๐—ฒ๐—ฟ๐—ถ๐—ฒ๐˜€
+ ๐—ž๐—ฒ๐—ฟ๐—น๐—ฒ๐˜† ๐—• ๐—น๐—ถ๐—ป๐—ฒ : ๐—›๐—ผ๐—ฟ๐—ถ๐˜‡๐—ผ๐—ป๐˜๐—ฎ๐—น ๐—น๐—ถ๐—ป๐—ฒ๐˜€ ๐—ถ๐—ป ๐—ฐ๐—ผ๐˜€๐˜๐—ผ๐—ฝ๐—ต๐—ฟ๐—ฒ๐—ป๐—ถ๐—ฐ ๐—ฎ๐—ป๐—ด๐—น๐—ฒ๐˜€
(Due to interstitial oedema > thickened interlobular septa & dilated lymphatics)
+ Pleural effusion in severe cases

55
Q

In the Mx of Pulmonary Oedema which steps are use to reduce pre-load

A
  1. Sit the patient UP
  2. CPAP by tight-fitting mask ( also reduce Pulmonary capillary Hydraulic gradient)
  3. Administration of nitrate ( also reduce afterload )

To correct Hypoxia - Give High Flow Oxygen
To Combat Fluid Overload - Diuretics

56
Q

What are the drugs Improve mortality in CHF?

A

IMPROVE MORTALITY IN CHF
* ACEi
* ARB
* Spironolactone
* B blocker
* SGLT2i
* Sacubitril
* Cardiac resynchronization therapy device

57
Q

Which Vaccination Is considered in HF patient ?

A

Influenza and Pneumococcal Vaccination

58
Q

ACE - I

A

EFFECT:

+ โ†“ Peripheral vasoconstriction
+ โ†“ Activation of sympathetic nervous system & RAAS
+ โ†“ Salt & water retention

A/E :
โœ“ Hypotension
โœ“ Hyperkalemia
โœ“ Renal impairment
โœ“ Dry cough
โœ“ Teratogenicity
+ Renal function & serum potassium must be monitored & should be checked 1โ€“2 weeks after starting therapy

59
Q

Effect Of diuretics on HF

A
  1. Reduce pre-load
  2. Improve pulmonary and venous congestion
  3. Reduce after-load and Ventricular volume
60
Q

Which drug reduces the risk of arrhythmia and Sudden death In HF

A

Beta Blocker

It is more effective than ACE i at reducing Mortality rate

61
Q

Which drug is used to control heart rate in HF not controlled by B Blocker

A

Ivabradin

62
Q

Cardiac Transplantation

A

Most common indications:
+ Coronary artery disease
+ Dilated cardiomyopathy

Contraindicated in:
+ Pulmonary vascular disease due to long-standing left heart failure
+ Complex congenital heart disease (Eisenmengerโ€™s syndrome)
+ Primary pulmonary hypertension

Complications:
+Rejection
+Accelerated Atherosclerosis
+Infection: CMV, Aspergillus

Heart-lung transplantation in Eisenmengerโ€™s syndrome

Lung transplantation for primary pulmonary hypertension

63
Q

Which condition HR does not change with breathing/ Posture change?

A

Absence of heart rate variation with breathing or changes in posture due to
+ Diabetic neuropathy
+ Autonomic neuropathy or
+ Increased sympathetic drive

64
Q

Causes of Sinus Bradycardia

A

Myocardial Infarction
Sinus node disease ( sick sinus syndrome)
Hypothermia
Hypothyroidism
Cholestatic jaundice
Raised ICP
Drugs ( B blocker, verapamil, Digoxin)

65
Q

Causes of sinus tachycardia

A

Anxiety
Fever
Anaemia
HF
Thyrotoxicosis
Phaeochromocytoma
Drugs ( B agonist)

66
Q

Common features of sinoatrial Disease

A

Sinus bradycardia
AV Block
Sinoatrial Block
Paroxysmal Atrial Fibrillation
Paroxysmal Atrial Tachycardia

67
Q

First Degree AV Block

A

๐—™๐—ถ๐—ฟ๐˜€๐˜ ๐—ฑ๐—ฒ๐—ด๐—ฟ๐—ฒ๐—ฒ ๐—”๐—ฉ ๐—ฏ๐—น๐—ผ๐—ฐ๐—ธ

๐—”๐—ฉ ๐—ฐ๐—ผ๐—ป๐—ฑ๐˜‚๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐—ถ๐˜€ ๐—ฑ๐—ฒ๐—น๐—ฎ๐˜†๐—ฒ๐—ฑ
๐—ฃ๐—ฅ ๐—ถ๐—ป๐˜๐—ฒ๐—ฟ๐˜ƒ๐—ฎ๐—น ๐—ถ๐˜€ ๐—ฝ๐—ฟ๐—ผ๐—น๐—ผ๐—ป๐—ด๐—ฒ๐—ฑ (> ๐Ÿฌ.๐Ÿฎ๐Ÿฌ ๐˜€๐—ฒ๐—ฐ)
๐—ก๐—ผ ๐—ฑ๐—ฟ๐—ผ๐—ฝ๐—ฝ๐—ฒ๐—ฑ ๐—ฏ๐—ฒ๐—ฎ๐˜
Rarely causes symptoms
Does not usually require treatment

68
Q

Third degree AV block

A

๐—ง๐—›๐—œ๐—ฅ๐——-๐——๐—˜๐—š๐—ฅ๐—˜๐—˜ ๐—”๐—ฉ ๐—•๐—Ÿ๐—ข๐—–๐—ž
Conduction fails completely. Atria & ventricles beat independently - known as AV dissociation

Escape rhythm arising in
+ ๐—”๐—ฉ ๐—ป๐—ผ๐—ฑ๐—ฒ ๐—ผ๐—ฟ ๐—•๐˜‚๐—ป๐—ฑ๐—น๐—ฒ ๐—ผ๐—ณ ๐—›๐—ถ๐˜€ (๐—ป๐—ฎ๐—ฟ๐—ฟ๐—ผ๐˜„ ๐—ค๐—ฅ๐—ฆ ) ๐—ผ๐—ฟ
+ ๐——๐—ถ๐˜€๐˜๐—ฎ๐—น ๐—ฃ๐˜‚๐—ฟ๐—ธ๐—ถ๐—ป๐—ท๐—ฒ ๐˜๐—ถ๐˜€๐˜€๐˜‚๐—ฒ๐˜€ (๐—ฏ๐—ฟ๐—ผ๐—ฎ๐—ฑ ๐—ค๐—ฅ๐—ฆ)

๐—ฆ๐—น๐—ผ๐˜„ (๐Ÿฎ๐Ÿฑโ€“๐Ÿฑ๐Ÿฌ/๐—บ๐—ถ๐—ป), ๐—ฟ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐—ฟ ๐—ฝ๐˜‚๐—น๐˜€๐—ฒ ๐˜๐—ต๐—ฎ๐˜ ๐—ฑ๐—ผ๐—ฒ๐˜€ ๐—ป๐—ผ๐˜ ๐˜ƒ๐—ฎ๐—ฟ๐˜† ๐˜„๐—ถ๐˜๐—ต ๐—ฒ๐˜…๐—ฒ๐—ฟ๐—ฐ๐—ถ๐˜€๐—ฒ (except congenital complete AV block)
๐—œ๐—ป๐—ฐ๐—ฟ๐—ฒ๐—ฎ๐˜€๐—ฒ๐—ฑ ๐˜€๐˜๐—ฟ๐—ผ๐—ธ๐—ฒ ๐˜ƒ๐—ผ๐—น๐˜‚๐—บ๐—ฒ
๐—Ÿ๐—ฎ๐—ฟ๐—ด๐—ฒ-๐˜ƒ๐—ผ๐—น๐˜‚๐—บ๐—ฒ ๐—ฝ๐˜‚๐—น๐˜€๐—ฒ
๐—–๐—ฎ๐—ป๐—ป๐—ผ๐—ป ๐—ฎ ๐˜„๐—ฎ๐˜ƒ๐—ฒ๐˜€
๐—ฉ๐—ฎ๐—ฟ๐—ถ๐—ฎ๐—ฏ๐—น๐—ฒ ๐—œ๐—ป๐˜๐—ฒ๐—ป๐˜€๐—ถ๐˜๐˜† ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐Ÿญ๐˜€๐˜ ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜ ๐˜€๐—ผ๐˜‚๐—ป๐—ฑ due to loss of AV synchrony. (๐—ฆ๐—•๐—” ๐—๐—จ๐—Ÿ ๐Ÿฎ๐Ÿฎ,JUL 23)

๐—ง๐˜†๐—ฝ๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฝ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป -
๐—ฅ๐—ฒ๐—ฐ๐˜‚๐—ฟ๐—ฟ๐—ฒ๐—ป๐˜ ๐˜€๐˜†๐—ป๐—ฐ๐—ผ๐—ฝ๐—ฒ ๐—ผ๐—ฟ โ€˜๐—ฆ๐˜๐—ผ๐—ธ๐—ฒ๐˜€ ๐—”๐—ฑ๐—ฎ๐—บ๐˜€โ€™ ๐—ฎ๐˜๐˜๐—ฎ๐—ฐ๐—ธ๐˜€
+ Sudden loss of consciousness that occurs without warning & results in collapse
+ A brief anoxic seizure (due to cerebral ischemia)
๐—ฃ๐—ฎ๐—น๐—น๐—ผ๐—ฟ & ๐—ฎ ๐—ฑ๐—ฒ๐—ฎ๐˜๐—ต-๐—น๐—ถ๐—ธ๐—ฒ ๐—ฎ๐—ฝ๐—ฝ๐—ฒ๐—ฎ๐—ฟ๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ฑ๐˜‚๐—ฟ๐—ถ๐—ป๐—ด ๐—ฎ๐˜๐˜๐—ฎ๐—ฐ๐—ธ & ๐—ฐ๐—ต๐—ฎ๐—ฟ๐—ฎ๐—ฐ๐˜๐—ฒ๐—ฟ๐—ถ๐˜€๐˜๐—ถ๐—ฐ ๐—ณ๐—น๐˜‚๐˜€๐—ต ๐˜„๐—ต๐—ฒ๐—ป ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜ ๐˜€๐˜๐—ฎ๐—ฟ๐˜๐˜€ ๐—ฏ๐—ฒ๐—ฎ๐˜๐—ถ๐—ป๐—ด ๐—ฎ๐—ด๐—ฎ๐—ถ๐—ป

*** Indication of permanent pacemaker :
๐—ฆ๐˜†๐—บ๐—ฝ๐˜๐—ผ๐—บ๐—ฎ๐˜๐—ถ๐—ฐ ๐—ฏ๐—ฟ๐—ฎ๐—ฑ๐˜†๐—ฎ๐—ฟ๐—ฟ๐—ต๐˜†๐˜๐—ต๐—บ๐—ถ๐—ฎ
๐— ๐—ผ๐—ฏ๐—ถ๐˜๐˜‡ ๐˜๐˜†๐—ฝ๐—ฒ ๐—œ๐—œ ๐—ผ๐—ฟ
๐—ง๐—ต๐—ถ๐—ฟ๐—ฑ-๐—ฑ๐—ฒ๐—ด๐—ฟ๐—ฒ๐—ฒ ๐—”๐—ฉ ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜ ๐—ฏ๐—น๐—ผ๐—ฐ๐—ธ

69
Q

Causes of AV Block

A

Idiopathic Fibrosis
MI
Inflammation:
Infective Endocarditis
Sarcoidosis
Chagaโ€™s Disease
Trauma
Drugs:
B blocker
Digoxin
Calcium Antagonist

70
Q

Atrial Flutter

A

๐—”๐—ง๐—ฅ๐—œ๐—”๐—Ÿ ๐—™๐—Ÿ๐—จ๐—ง๐—ง๐—˜๐—ฅ
Characterized by a ๐—น๐—ฎ๐—ฟ๐—ด๐—ฒ (๐—บ๐—ฎ๐—ฐ๐—ฟ๐—ผ) ๐—ฟ๐—ฒ-๐—ฒ๐—ป๐˜๐—ฟ๐˜† ๐—ฐ๐—ถ๐—ฟ๐—ฐ๐˜‚๐—ถ๐˜, ๐˜‚๐˜€๐˜‚๐—ฎ๐—น๐—น๐˜† ๐˜„๐—ถ๐˜๐—ต๐—ถ๐—ป ๐—ฟ๐—ถ๐—ด๐—ต๐˜ ๐—ฎ๐˜๐—ฟ๐—ถ๐˜‚๐—บ ๐—ฒ๐—ป๐—ฐ๐—ถ๐—ฟ๐—ฐ๐—น๐—ถ๐—ป๐—ด ๐˜๐—ฟ๐—ถ๐—ฐ๐˜‚๐˜€๐—ฝ๐—ถ๐—ฑ ๐—ฎ๐—ป๐—ป๐˜‚๐—น๐˜‚๐˜€

The atrial rate is approximately 300/min and is usually associated with 2: 1, 3: 1, or 4: 1 AV block.

๐—”๐˜๐—ฟ๐—ถ๐—ฎ๐—น ๐—ณ๐—น๐˜‚๐˜๐˜๐—ฒ๐—ฟ ๐˜€๐—ต๐—ผ๐˜‚๐—น๐—ฑ ๐—ฏ๐—ฒ ๐˜€๐˜‚๐˜€๐—ฝ๐—ฒ๐—ฐ๐˜๐—ฒ๐—ฑ ๐˜„๐—ต๐—ฒ๐—ป ๐˜๐—ต๐—ฒ๐—ฟ๐—ฒ ๐—ถ๐˜€ ๐—ฎ ๐—ป๐—ฎ๐—ฟ๐—ฟ๐—ผ๐˜„-๐—ฐ๐—ผ๐—บ๐—ฝ๐—น๐—ฒ๐˜… ๐˜๐—ฎ๐—ฐ๐—ต๐˜†๐—ฐ๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ฎ ๐—ผ๐—ณ ๐Ÿญ๐Ÿฑ๐Ÿฌ/๐—บ๐—ถ๐—ป

๐—–๐—ฎ๐—ฟ๐—ผ๐˜๐—ถ๐—ฑ ๐˜€๐—ถ๐—ป๐˜‚๐˜€ ๐—ฝ๐—ฟ๐—ฒ๐˜€๐˜€๐˜‚๐—ฟ๐—ฒ ๐—ผ๐—ฟ ๐—œ๐—ฉ ๐—ฎ๐—ฑ๐—ฒ๐—ป๐—ผ๐˜€๐—ถ๐—ป๐—ฒ ๐—บ๐—ฎ๐˜† ๐—ต๐—ฒ๐—น๐—ฝ ๐˜๐—ผ ๐—ฒ๐˜€๐˜๐—ฎ๐—ฏ๐—น๐—ถ๐˜€๐—ต ๐—ฑ๐˜… by temporarily โ†‘ degree of AV block & revealing flutter waves

ECG shows saw-tooth flutter waves

Management

Rate control : Digoxin, ฮฒ-blockers or verapamil or
Rhythm control: DC cardioversion or catheter ablation
๐—–๐—น๐—ฎ๐˜€๐˜€ ๐—œ๐—ฐ ๐—ฎ๐—ป๐˜๐—ถ-๐—ฎ๐—ฟ๐—ฟ๐—ต๐˜†๐˜๐—ต๐—บ๐—ถ๐—ฐ ๐—ฑ๐—ฟ๐˜‚๐—ด๐˜€ ๐˜€๐˜‚๐—ฐ๐—ต ๐—ฎ๐˜€ ๐—ณ๐—น๐—ฒ๐—ฐ๐—ฎ๐—ถ๐—ป๐—ถ๐—ฑ๐—ฒ ๐—ฎ๐—ฟ๐—ฒ ๐—ฐ๐—ผ๐—ป๐˜๐—ฟ๐—ฎ๐—ถ๐—ป๐—ฑ๐—ถ๐—ฐ๐—ฎ๐˜๐—ฒ๐—ฑ

*** Catheter ablation :
+ > ๐Ÿต๐Ÿฌ% ๐—ฐ๐—ต๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ณ ๐—ฝ๐—ฒ๐—ฟ๐—บ๐—ฎ๐—ป๐—ฒ๐—ป๐˜ ๐—ฐ๐˜‚๐—ฟ๐—ฒ
+ ๐—ง๐—ฟ๐—ฒ๐—ฎ๐˜๐—บ๐—ฒ๐—ป๐˜ ๐—ผ๐—ณ ๐—ฐ๐—ต๐—ผ๐—ถ๐—ฐ๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐—ฝ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜๐˜€ ๐˜„๐—ถ๐˜๐—ต ๐—ฝ๐—ฒ๐—ฟ๐˜€๐—ถ๐˜€๐˜๐—ฒ๐—ป๐˜ ๐˜€๐˜†๐—บ๐—ฝ๐˜๐—ผ๐—บ๐˜€

71
Q

What is the most common sustained Cardiac arrhythmia ?

A

๐—”๐—ง๐—ฅ๐—œ๐—”๐—Ÿ ๐—™๐—œ๐—•๐—ฅ๐—œ๐—Ÿ๐—Ÿ๐—”๐—ง๐—œ๐—ข๐—ก

*** ๐—”๐˜๐—ฟ๐—ถ๐—ฎ๐—น ๐—ณ๐—ถ๐—ฏ๐—ฟ๐—ถ๐—น๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป (๐—”๐—™) - ๐—บ๐—ผ๐˜€๐˜ ๐—ฐ๐—ผ๐—บ๐—บ๐—ผ๐—ป ๐˜€๐˜‚๐˜€๐˜๐—ฎ๐—ถ๐—ป๐—ฒ๐—ฑ ๐—ฐ๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ฎ๐—ฐ ๐—ฎ๐—ฟ๐—ฟ๐—ต๐˜†๐˜๐—ต๐—บ๐—ถ๐—ฎ (๐—ฆ๐—•๐—”)

Complex arrhythmia characterized by both - ๐—ฎ๐—ฏ๐—ป๐—ผ๐—ฟ๐—บ๐—ฎ๐—น ๐—ฎ๐˜‚๐˜๐—ผ๐—บ๐—ฎ๐˜๐—ถ๐—ฐ ๐—ณ๐—ถ๐—ฟ๐—ถ๐—ป๐—ด
- ๐—ฝ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ณ ๐—บ๐˜‚๐—น๐˜๐—ถ๐—ฝ๐—น๐—ฒ ๐—ถ๐—ป๐˜๐—ฒ๐—ฟ๐—ฎ๐—ฐ๐˜๐—ถ๐—ป๐—ด ๐—ฟ๐—ฒ-๐—ฒ๐—ป๐˜๐—ฟ๐˜† ๐—ฐ๐—ถ๐—ฟ๐—ฐ๐˜‚๐—ถ๐˜๐˜€ ๐˜„๐—ถ๐˜๐—ต๐—ถ๐—ป ๐—ฎ๐˜๐—ฟ๐—ถ๐—ฎ

Ectopic beats arising ๐—ณ๐—ฟ๐—ผ๐—บ
- ๐—ฐ๐—ผ๐—ป๐—ฑ๐˜‚๐—ฐ๐˜๐—ถ๐—ป๐—ด ๐˜๐—ถ๐˜€๐˜€๐˜‚๐—ฒ ๐—ถ๐—ป ๐—ฝ๐˜‚๐—น๐—บ๐—ผ๐—ป๐—ฎ๐—ฟ๐˜† ๐˜ƒ๐—ฒ๐—ถ๐—ป๐˜€
- ๐—ฑ๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ๐—ฑ ๐—ฎ๐˜๐—ฟ๐—ถ๐—ฎ๐—น ๐˜๐—ถ๐˜€๐˜€๐˜‚๐—ฒ

๐—”๐˜๐—ฟ๐—ถ๐—ฎ ๐—ฏ๐—ฒ๐—ฎ๐˜ ๐—ฟ๐—ฎ๐—ฝ๐—ถ๐—ฑ๐—น๐˜† ๐—ฏ๐˜‚๐˜ ๐—ถ๐—ป ๐—ฎ๐—ป ๐˜‚๐—ป๐—ฐ๐—ผ๐—ผ๐—ฟ๐—ฑ๐—ถ๐—ป๐—ฎ๐˜๐—ฒ๐—ฑ & ๐—ถ๐—ป๐—ฒ๐—ณ๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—บ๐—ฎ๐—ป๐—ป๐—ฒ๐—ฟ
Ventricles are activated irregularly at a rate determined by conduction through the AV node
This produces ๐—ฐ๐—ต๐—ฎ๐—ฟ๐—ฎ๐—ฐ๐˜๐—ฒ๐—ฟ๐—ถ๐˜€๐˜๐—ถ๐—ฐ โ€˜๐—ถ๐—ฟ๐—ฟ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐—ฟ๐—น๐˜† ๐—ถ๐—ฟ๐—ฟ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐—ฟโ€™ ๐—ฝ๐˜‚๐—น๐˜€๐—ฒ

72
Q

ECG Findings OF AF

A

ECG shows
+ ๐—ก๐—ผ๐—ฟ๐—บ๐—ฎ๐—น ๐—ฏ๐˜‚๐˜ ๐—ถ๐—ฟ๐—ฟ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐—ฟ ๐—ค๐—ฅ๐—ฆ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—น๐—ฒ๐˜…๐—ฒ๐˜€
+ ๐—ก๐—ผ ๐—ฃ ๐˜„๐—ฎ๐˜ƒ๐—ฒ๐˜€
+ ๐—•๐—ฎ๐˜€๐—ฒ๐—น๐—ถ๐—ป๐—ฒ ๐—บ๐—ฎ๐˜† ๐˜€๐—ต๐—ผ๐˜„ ๐—ถ๐—ฟ๐—ฟ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐—ฟ ๐—ณ๐—ถ๐—ฏ๐—ฟ๐—ถ๐—น๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐˜„๐—ฎ๐˜ƒ๐—ฒ๐˜€

73
Q

Mx of Atrial fibrillation

A

Management

๐—ฃ๐—ฎ๐—ฟ๐—ผ๐˜…๐˜†๐˜€๐—บ๐—ฎ๐—น ๐—”๐—™
Occasional attacks of AF that are well tolerated do not necessarily require treatment.
๐—•๐—ฒ๐˜๐—ฎ-๐—ฏ๐—น๐—ผ๐—ฐ๐—ธ๐—ฒ๐—ฟ๐˜€ - ๐—™๐—ถ๐—ฟ๐˜€๐˜-๐—น๐—ถ๐—ป๐—ฒ ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜† (๐—ฆ๐—•๐—”)
The most effective agent for prevention is amiodarone (Side effects restrict its use)

๐—ฃ๐—ฒ๐—ฟ๐˜€๐—ถ๐˜€๐˜๐—ฒ๐—ป๐˜ ๐—”๐—™
Principle of Rx
+ Rate or rhythm control
+ Prophylaxis against thromboembolism

Rhythm control
Indication
+ Troublesome symptoms
+ Treatable underlying cause
+ No structural heart disease
+ Young patient
+ Duration < 3 months

Option :
+ Electrical cardioversion
+ Pharmacological cardioversion

If present < 48 hours: Immediate cardioversion

+ ๐—ฆ๐˜๐—ฎ๐—ฏ๐—น๐—ฒ & ๐—ป๐—ผ ๐—ต/๐—ผ ๐—ผ๐—ณ ๐˜€๐˜๐—ฟ๐˜‚๐—ฐ๐˜๐˜‚๐—ฟ๐—ฎ๐—น ๐—ต๐—ฒ๐—ฎ๐—ฟ๐˜ ๐—ฑ๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ : ๐—œ๐—ฉ ๐—™๐—น๐—ฒ๐—ฐ๐—ฎ๐—ถ๐—ป๐—ถ๐—ฑ๐—ฒ
+ ๐—ฆ๐˜๐—ฟ๐˜‚๐—ฐ๐˜๐˜‚๐—ฟ๐—ฎ๐—น ๐—ผ๐—ฟ ๐—œ๐—›๐——: ๐—”๐—บ๐—ถ๐—ผ๐—ฑ๐—ฎ๐—ฟ๐—ผ๐—ป๐—ฒ
+ DC cardioversion can be used

Rate control
Option
+ ๐Ÿญ๐˜€๐˜ ๐—ฐ๐—ต๐—ผ๐—ถ๐—ฐ๐—ฒ : ฮฒ-๐—ฏ๐—น๐—ผ๐—ฐ๐—ธ๐—ฒ๐—ฟ (๐—ฆ๐—•๐—”)
+ ๐—”๐—น๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐˜ƒ๐—ฒ : ๐—ฅ๐—ฎ๐˜๐—ฒ-๐—น๐—ถ๐—บ๐—ถ๐˜๐—ถ๐—ป๐—ด ๐—–๐—–๐—• (๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ฎ๐—บ๐—ถ๐—น / ๐—ฑ๐—ถ๐—น๐˜๐—ถ๐—ฎ๐˜‡๐—ฒ๐—บ)
+ ๐—œ๐—ณ ๐—ต๐˜†๐—ฝ๐—ผ๐˜๐—ฒ๐—ป๐˜€๐—ถ๐—ผ๐—ป ๐—ผ๐—ฟ ๐—›๐—™ ๐—ฝ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ป๐˜: ๐——๐—ถ๐—ด๐—ผ๐˜…๐—ถ๐—ป
๐—–๐—ฎ๐—น๐—ฐ๐—ถ๐˜‚๐—บ ๐—ฐ๐—ต๐—ฎ๐—ป๐—ป๐—ฒ๐—น ๐—ฎ๐—ป๐˜๐—ฎ๐—ด๐—ผ๐—ป๐—ถ๐˜€๐˜๐˜€ ๐˜€๐—ต๐—ผ๐˜‚๐—น๐—ฑ ๐—ป๐—ผ๐˜ ๐—ฏ๐—ฒ ๐˜‚๐˜€๐—ฒ๐—ฑ ๐˜„๐—ถ๐˜๐—ต ฮฒ-๐—ฏ๐—น๐—ผ๐—ฐ๐—ธ๐—ฒ๐—ฟ๐˜€ ๐—ฏ๐—ฒ๐—ฐ๐—ฎ๐˜‚๐˜€๐—ฒ ๐—ผ๐—ณ ๐—ฟ๐—ถ๐˜€๐—ธ ๐—ผ๐—ณ ๐—ฏ๐—ฟ๐—ฎ๐—ฑ๐˜†๐—ฐ๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ฎ

Thromboprophylaxis
๐—”๐—™ ๐˜€๐—ฒ๐—ฐ๐—ผ๐—ป๐—ฑ๐—ฎ๐—ฟ๐˜† ๐˜๐—ผ ๐— ๐—ถ๐˜๐—ฟ๐—ฎ๐—น ๐˜ƒ๐—ฎ๐—น๐˜ƒ๐—ฒ ๐—ฑ๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ : ๐—š๐—ถ๐˜ƒ๐—ฒ ๐—ฎ๐—ป๐˜๐—ถ๐—ฐ๐—ผ๐—ฎ๐—ด๐˜‚๐—น๐—ฎ๐—ป๐˜
๐—”๐—™ ๐˜„๐—ถ๐˜๐—ต๐—ผ๐˜‚๐˜ ๐—บ๐—ถ๐˜๐—ฟ๐—ฎ ๐˜ƒ๐—ฎ๐—น๐˜ƒ๐—ฒ ๐—ฑ๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ : ๐——๐—ผ ๐—–๐—›๐—”๐Ÿฎ ๐——๐—ฆ๐Ÿฎ-๐—ฉ๐—”๐—ฆ๐—ฐ ๐˜€๐˜๐—ฟ๐—ผ๐—ธ๐—ฒ ๐—ฟ๐—ถ๐˜€๐—ธ ๐˜€๐—ฐ๐—ผ๐—ฟ๐—ถ๐—ป๐—ด
๐——๐—ถ๐—ฟ๐—ฒ๐—ฐ๐˜-๐—ฎ๐—ฐ๐˜๐—ถ๐—ป๐—ด ๐—ผ๐—ฟ๐—ฎ๐—น ๐—ฎ๐—ป๐˜๐—ถ๐—ฐ๐—ผ๐—ฎ๐—ด๐˜‚๐—น๐—ฎ๐—ป๐˜๐˜€ (๐——๐—ข๐—”๐—–๐˜€)
๐—ต๐—ฎ๐˜ƒ๐—ฒ ๐—น๐—ฎ๐—ฟ๐—ด๐—ฒ๐—น๐˜† ๐—ฟ๐—ฒ๐—ฝ๐—น๐—ฎ๐—ฐ๐—ฒ๐—ฑ ๐˜„๐—ฎ๐—ฟ๐—ณ๐—ฎ๐—ฟ๐—ถ๐—ป ๐—ณ๐—ผ๐—ฟ ๐˜€๐˜๐—ฟ๐—ผ๐—ธ๐—ฒ ๐—ฝ๐—ฟ๐—ฒ๐˜ƒ๐—ฒ๐—ป๐˜๐—ถ๐—ผ๐—ป ๐—ถ๐—ป ๐—”๐—™

74
Q

What are the DOACs and What are their advantage ?

A

DOACs include
+ Factor Xa inhibitors (Rivaroxaban, apixaban & edoxaban)
+ Direct thrombin inhibitor (Dabigatran)

Advantage
+ ๐—˜๐—ณ๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ฎ๐˜ ๐—ฝ๐—ฟ๐—ฒ๐˜ƒ๐—ฒ๐—ป๐˜๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฟ๐—ผ๐—บ๐—ฏ๐—ผ๐˜๐—ถ๐—ฐ ๐˜€๐˜๐—ฟ๐—ผ๐—ธ๐—ฒ
+ ๐—š๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐—น๐—น๐˜† ๐—ฎ๐˜€๐˜€๐—ผ๐—ฐ๐—ถ๐—ฎ๐˜๐—ฒ๐—ฑ ๐˜„๐—ถ๐˜๐—ต ๐—ฎ ๐—น๐—ผ๐˜„๐—ฒ๐—ฟ ๐—ฟ๐—ถ๐˜€๐—ธ ๐—ผ๐—ณ ๐—ถ๐—ป๐˜๐—ฟ๐—ฎ๐—ฐ๐—ฟ๐—ฎ๐—ป๐—ถ๐—ฎ๐—น ๐—ต๐—ฎ๐—ฒ๐—บ๐—ผ๐—ฟ๐—ฟ๐—ต๐—ฎ๐—ด๐—ฒ
+ ๐—Ÿ๐—ฎ๐—ฐ๐—ธ ๐—ผ๐—ณ ๐—ฟ๐—ฒ๐—พ๐˜‚๐—ถ๐—ฟ๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐—ณ๐—ผ๐—ฟ ๐—บ๐—ผ๐—ป๐—ถ๐˜๐—ผ๐—ฟ๐—ถ๐—ป๐—ด
+ ๐—™๐—ฒ๐˜„๐—ฒ๐—ฟ ๐—ฑ๐—ฟ๐˜‚๐—ด & ๐—ณ๐—ผ๐—ผ๐—ฑ ๐—ถ๐—ป๐˜๐—ฒ๐—ฟ๐—ฎ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐˜€

75
Q

Which agent revers the effect of DOACs

A

Agents that reverse effects of DOACs include
+ ๐—œ๐—ฑ๐—ฎ๐—ฟ๐˜‚๐—ฐ๐—ถ๐˜‡๐˜‚๐—บ๐—ฎ๐—ฏ : ๐—•๐—ถ๐—ป๐—ฑ๐˜€ ๐˜๐—ผ ๐—ฑ๐—ฎ๐—ฏ๐—ถ๐—ด๐—ฎ๐˜๐—ฟ๐—ฎ๐—ป
+ ๐—”๐—ป๐—ฑ๐—ฒ๐˜…๐—ฎ๐—ป๐—ฒ๐˜ ๐—ฎ๐—น๐—ณ๐—ฎ : ๐—•๐—ถ๐—ป๐—ฑ๐˜€ ๐˜๐—ผ ๐—ฎ๐—ฝ๐—ถ๐˜…๐—ฎ๐—ฏ๐—ฎ๐—ป & ๐—ฟ๐—ถ๐˜ƒ๐—ฎ๐—ฟ๐—ผ๐˜…๐—ฎ๐—ฏ๐—ฎ๐—ป.

76
Q

What are the SVT

A

AVNRT
AVRT
AT

77
Q

AVNRT

A

HR: 120-240
Duration: A few Seconds to many Hours
Usually Occurs in the absence of Structural Heart Disease
ECG: Tachycardia with normal QRS Complex
MX: Acute Episode: Carotid sinus Pressure or Valsalva manoeuvre
To restore Sinus rhythm: IV Adenosine / Verapamil
If severe Hemodynamic compromise: DC Cardioversion
Recurrent SVT: Catheter ablation is the most effective therapy

78
Q

AVRT

A

ECG: Shortened PR Interval
Delta Wave ( slurred Initial deflection of QRS Complex)

Catheter ablation is the first line and most effective and curative treatment

Prophylactic: Flecainide and Propafenone

79
Q

What are the pathognomonic features of VT

A

AV dissociation
Capture / Fusion Beats

80
Q

Where VT Occur most commonly?

A

Acute MI
Chronic CAD
Cardiomyopathy

VT is associated with
Extensive Ventricular disease
Impaired Left ventricular function
Ventricular aneurysm

81
Q

Which conditions it become difficult to distinguish between VT and SVT on ECG

A

It may be difficult to distinguish VT from SVT with
+ Bundle branch block
+ Pre-excitation (WPW syndrome)on ECG

Features In favor of VT are
H/O MI
AV Dissociation
Capture/ Fusion beats
Extreme Left axis deviation
Very Broad QRS Complex (140ms)
Irresponsive to carotid sinus massage Or IV adenosine

82
Q

Idioventricular Rhythm

A

Occurs to the patient recovering from MI

Rate: Slightly above the preceding sinus node and below 120 bpm
Self-limiting
Asymptomatic
Reflect reperfusion of Infarct territory and may be a good sign

do not require Treatment

83
Q

VT with Systolic BP less than 90 mmHg what is mx?

A

Synchronized DC Cardioversion

If the arrhythmia is well tolerated then IV amiodarone

84
Q

Treatment of Choice for VT in Normal heart ?

A

Catheter ablation

85
Q

Torsades de pointes

A

๐—ง๐—ข๐—ฅ๐—ฆ๐—”๐——๐—˜๐—ฆ ๐——๐—˜ ๐—ฃ๐—ข๐—œ๐—ก๐—ง๐—˜๐—ฆ
This form of ๐—ฝ๐—ผ๐—น๐˜†๐—บ๐—ผ๐—ฟ๐—ฝ๐—ต๐—ถ๐—ฐ ๐—ฉ๐—ง ๐—ถ๐˜€ ๐—ฎ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—น๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ณ ๐—ฝ๐—ฟ๐—ผ๐—น๐—ผ๐—ป๐—ด๐—ฒ๐—ฑ ๐˜ƒ๐—ฒ๐—ป๐˜๐—ฟ๐—ถ๐—ฐ๐˜‚๐—น๐—ฎ๐—ฟ ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—น๐—ฎ๐—ฟ๐—ถ๐˜€๐—ฎ๐˜๐—ถ๐—ผ๐—ป (๐—ฝ๐—ฟ๐—ผ๐—น๐—ผ๐—ป๐—ด๐—ฒ๐—ฑ ๐—ค๐—ง ๐—ถ๐—ป๐˜๐—ฒ๐—ฟ๐˜ƒ๐—ฎ๐—น)

ECG: ๐—ฅ๐—ฎ๐—ฝ๐—ถ๐—ฑ ๐—ถ๐—ฟ๐—ฟ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐—ฟ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—น๐—ฒ๐˜…๐—ฒ๐˜€ that seem to twist around baseline as ๐—บ๐—ฒ๐—ฎ๐—ป ๐—ค๐—ฅ๐—ฆ ๐—ฎ๐˜…๐—ถ๐˜€ ๐—ฐ๐—ต๐—ฎ๐—ป๐—ด๐—ฒ๐˜€

MX: IV Mg should be given in all cases (8mmol over 15min then 72 mmol over 24 hours )

86
Q

Congenital Long QT syndrome

A

Congenital long QT: Mutations in genes that code for ๐—ฐ๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ฎ๐—ฐ ๐—ž ๐—ผ๐—ฟ ๐—ก๐—ฎ ๐—ฐ๐—ต๐—ฎ๐—ป๐—ป๐—ฒ๐—น๐˜€

Triggers
+ Long QT1 : Vigorous exercise
+ Long QT2 : Sudden noise
+ Long QT3 : Sleep

๐—–๐—ผ๐—ป๐—ด๐—ฒ๐—ป๐—ถ๐˜๐—ฎ๐—น ๐—น๐—ผ๐—ป๐—ด ๐—ค๐—ง: ๐—•๐—ฒ๐˜๐—ฎ ๐—ฏ๐—น๐—ผ๐—ฐ๐—ธ๐—ฒ๐—ฟ๐˜€ (๐—ฆ๐—•๐—”)
๐—ฅ๐—ฒ๐˜€๐—ถ๐˜€๐˜๐—ฎ๐—ป๐˜ ๐—ฎ๐—ฟ๐—ฟ๐—ต๐˜†๐˜๐—ต๐—บ๐—ถ๐—ฎ: ๐—Ÿ๐—ฒ๐—ณ๐˜ ๐˜€๐˜๐—ฒ๐—น๐—น๐—ฎ๐˜๐—ฒ ๐—ด๐—ฎ๐—ป๐—ด๐—น๐—ถ๐—ผ๐—ป ๐—ฏ๐—น๐—ผ๐—ฐ๐—ธ

87
Q

Brugada Syndrome

A

Genetic Disorder Present with Polymorphic VT and Sudden death
Commonly Caused By Mutation In the SCN5A Gene Which encodes Na Channels
ECG: RBBB, ST elevation In The V1 and V2 without prolongation of the QT interval

Mx: Implantable Defibrillator

88
Q

Classification Of Anti-Arrhythmic Drug According TO M/A

A

Class 1: Membrane stabilizing agents ( Na channel blockers)
1(a) Prolong AP: Disopyramide, Quinidine
1(b) Shorten AP: Lidocaine , Mexiletine
1(c) No effect on AP: Flecainide, Propafenone

Class 2: B Blocker
Atenolol, Bisoprolol, metoprolol

Class 3: Drugs Whose Main Effect to Prolong AP
Amiodarone, Dronedarone, Sotalol

Class 4: Slow Calcium Channel blocker:
Diltiazem, Verapamil

89
Q

Classification of Anti-Arrhythmic drug acc to site of Action

A

SA Node:
Atropine
B blocker
Verapamil
Diltiazem

AV node:
Adenosine
B blocker
Digoxin
Diltiazem
Verapamil

Ventricles:
Lidocaine
Mexiletine
B blocker

Atria, Ventricle accessory Conducting tissue
Class 1(a)+ 1(C) + amiodarone

90
Q

Digoxin Toxicity

A

Extra cardiac:
Anorexia, Nausea , Vomiting, Diarrhoea, Altered Color vision (xanthopsia)

Cardiac:
Bradycardia
Multiple Ventricular ectopic
Ventricular bigeminy
Atrial Tachycardia
Ventricular Tachycardia
Ventricular fibrillation

91
Q

Permanent Pace maker Indication and Complication

A

Indication:
Single Chamber :
Atrial pacing: Sinoatrial Disease without AV block
Ventricular Pacing: Continuous AF and bradycardia

Dual Chamber:
2nd and 3rd Degree heart block

Complication:
Early :
Pneumothorax
Cardiac Tamponade
Infection
Lead displacement

Late:
Infection
Erosion of the lead
Lead fracture
Chronic pain

92
Q

What is the most powerful independent risk factor for atherosclerosis

A

AGE

93
Q

What is the imp modifiable risk factor for CAD?

A

Smoking

94
Q

What are the six stages of atherosclerosis

A

Initial lesion
Fatty streak
Intermediate lesion
atheroma
Fibroatheroma
Complicated

95
Q

Coronary blood flow usually occurs in-

A

Diastole

96
Q

Factors Influencing Myocardial Oxygen supply and Coronary Blood Flow

A

Myocardial Oxygen Supply:
HR
BP
Myocardial Contractility
LVH
Valve disease

Coronary Blood Flow:
Duration of Diastole
Coronary perfusion pressure
Coronary Vasomotor tone
Oxygenation:
Hb
O2 Saturation

97
Q

What is prinzmetalโ€™s angina

A

Coronary artery Spasm+ Transient ST elevation

98
Q

Three Characteristics features of angina

A
  1. Constricting Discomfort in the center of the chest, Or in the neck, Shoulder, Jaw and arms
  2. Precipitate by Physical Exertion
  3. Relieved By rest (GTN) within 5 minutes
99
Q

What is the most common cause of angina pectoris

A

Coronary Atherosclerosis

100
Q

Syndrome X

A

+ ๐—ง๐˜†๐—ฝ๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฎ๐—ป๐—ด๐—ถ๐—ป๐—ฎ ๐—ผ๐—ป ๐—ฒ๐—ณ๐—ณ๐—ผ๐—ฟ๐˜
+ ๐—ก๐—ผ๐—ฟ๐—บ๐—ฎ๐—น ๐—ฐ๐—ผ๐—ฟ๐—ผ๐—ป๐—ฎ๐—ฟ๐˜† ๐—ฎ๐—ฟ๐˜๐—ฒ๐—ฟ๐—ถ๐—ฒ๐˜€ ๐—ผ๐—ป ๐—ฎ๐—ป๐—ด๐—ถ๐—ผ๐—ด๐—ฟ๐—ฎ๐—ฝ๐—ต๐˜†
+ ๐—ข๐—ฏ๐—ท๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ฒ๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ณ ๐—บ๐˜†๐—ผ๐—ฐ๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ฎ๐—น ๐—ถ๐˜€๐—ฐ๐—ต๐—ฎ๐—ฒ๐—บ๐—ถ๐—ฎ ๐—ผ๐—ป ๐˜€๐˜๐—ฟ๐—ฒ๐˜€๐˜€ ๐˜๐—ฒ๐˜€๐˜๐—ถ๐—ป๐—ด
+ ๐— ๐—ผ๐—ฟ๐—ฒ ๐—ฐ๐—ผ๐—บ๐—บ๐—ผ๐—ป ๐—ถ๐—ป ๐˜„๐—ผ๐—บ๐—ฒ๐—ป
+ ๐—š๐—ผ๐—ผ๐—ฑ ๐—ฝ๐—ฟ๐—ผ๐—ด๐—ป๐—ผ๐˜€๐—ถ๐˜€
+ ๐—ฅ๐—ฒ๐˜€๐—ฝ๐—ผ๐—ป๐—ฑ ๐˜ƒ๐—ฎ๐—ฟ๐—ถ๐—ฎ๐—ฏ๐—น๐˜† ๐˜๐—ผ ๐—ฎ๐—ป๐˜๐—ถ ๐—ฎ๐—ป๐—ด๐—ถ๐—ป๐—ฎ๐—น ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜†

101
Q

False Positive result on ECG can be found in

A

Digoxin toxicity
LVH
BBB
WPW Syndrome

102
Q

Nitrates

A

Lowered Preload and afterload which reduce myocardial Oxygen Demand.
Coronary Vasodilation which increases Oxygen Supply

A/E:
Headache
Hypotension
Syncope rarely

103
Q

Which anti-anginal drug is safe In HF

A

Ivabradine (If Channel antagonist)

104
Q

Which arteries are used for Bypass grafting

A

Internal mammary artery
Radial Artery
Saphenous vain

105
Q

Characteristics of Unstable angina

A

Unstable angina
+ New-onset or rapidly worsening angina (crescendo angina)
+ Angina on minimal exertion
+ Angina at rest in the absence of myocardial damage

106
Q

Dx criteria of AMI

A

Fall/ Rise Troponin level with at least one value above the 99th centile upper reference limit with one of the following:
- Symptoms of AMI
- New Ischaemic ECG Change
- Pathological Q on ECG
- New loss of viable myocardium and regional wall abnormality on imaging
- Identification of Coronary thrombus on angiography or autopsy

107
Q

Common Arrhythmia in ACS

A

VF
VT
Ventricular Ectopic
AF
AV Block
Idioventricular Rhythm
Sinus Bradycardia

108
Q

Patient H/O ACS having recurrent angina with dynamic ECG change Should be treated with

A

Glycoprotein IIb/IIIa receptor antagonist
Tirofiban
Abciximab

109
Q

Pericarditis

A

Occurs on 2nd and 3rd day
Different pain develops on the same side and may worse sometime, sometimes it may only present during INSPIRATION
A Pericardial rub may be present

RX: Opiate based analgesic

110
Q

Persistent Fever, Pericarditis, Pleurisy

A

Dressler syndrome

Due to autoimmunity
Usually occurs a few days or a few months after MI

Rx with: High Dose aspirin
(NSAIDs, Glucocorticoid steroid may be required)

111
Q

Pan systolic murmur + Pulmonary Oedema with 3rd heart sound after MI

A

Papillary Muscle rupture confirmed by Echocardiography

112
Q

Pan systolic murmur + RHF + Haemodynamic deterioration

A

Ventricular septal rupture

Confirmed by Echocardiography and cardiac catheterization

113
Q

Which drug should be given to prevent ventricular remodeling and HF

A
  1. ACE Inhibitors
  2. Beta blocker
  3. Mineralocorticoid Antagonist
114
Q

Ventricular Aneurysm

A

โ™ฆ๏ธ Complications of aneurysm

+ Heart failure

+ Ventricular arrhythmias

+ Mural thrombus & systemic embolism

โ™ฆ๏ธ Other features

+ Paradoxical impulse on chest wall,

+ ๐—ฃ๐—ฒ๐—ฟ๐˜€๐—ถ๐˜€๐˜๐—ฒ๐—ป๐˜ ๐—ฆ๐—ง ๐—ฒ๐—น๐—ฒ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ป ๐—˜๐—–๐—š (๐—ฆ๐—•๐—”)

+ Sometimes an unusual bulge from cardiac silhouette on chest X-ray

โ™ฆ๏ธ ๐—˜๐—ฐ๐—ต๐—ผ๐—ฐ๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ผ๐—ด๐—ฟ๐—ฎ๐—ฝ๐—ต๐˜† ๐—ถ๐˜€ ๐—ฑ๐—ถ๐—ฎ๐—ด๐—ป๐—ผ๐˜€๐˜๐—ถ๐—ฐ

115
Q

What is the earliest change in the ECG in MI

A

๐—˜๐—ฎ๐—ฟ๐—น๐—ถ๐—ฒ๐˜€๐˜ ๐—˜๐—–๐—š ๐—ฐ๐—ต๐—ฎ๐—ป๐—ด๐—ฒ : ๐—ฆ๐—ง-๐˜€๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜ ๐—ฑ๐—ฒ๐˜ƒ๐—ถ๐—ฎ๐˜๐—ถ๐—ผ๐—ป (๐—ฆ๐—•๐—”)

116
Q

ECG change According to vessel occlusion

A

Proximal occlusion of a major coronary artery :

๐Ÿ”นST elevation (or new bundle branch block) >

๐Ÿ”นDiminution in size of R & in transmural infarction, development of Q

>

๐Ÿ”นT wave invertion (Persists after ST segment has returned to normal)

*** Partial occlusion of a major vessel or complete occlusion of a minor vessel

๐Ÿ”น Causing unstable angina or partial thickness (subendocardial) MI

๐Ÿ”น ST depression & T wave change

๐Ÿ”น Some loss of R wave

๐Ÿ”น Absence of Q wave

๐Ÿ”น No ST elevation

117
Q

ECG changes in Lead V1- V4 indicate

A

Anteroseptal infarction

118
Q

ECG changes in lead V4 - V6, avL and Lead I indicate

A

Anterolateral infarction

119
Q

ECG changes in Lead II,III and aVF indicate

A

Inferior infarction

120
Q

Which lead change will occur in posterior LV infarction

A

๐—ฃ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ๐—ถ๐—ผ๐—ฟ ๐˜„๐—ฎ๐—น๐—น ๐—ผ๐—ณ ๐—Ÿ๐—ฉ : ๐—ฅ๐—ฒ๐—ฐ๐—ถ๐—ฝ๐—ฟ๐—ผ๐—ฐ๐—ฎ๐—น ๐—ฆ๐—ง ๐—ฑ๐—ฒ๐—ฝ๐—ฟ๐—ฒ๐˜€๐˜€๐—ถ๐—ผ๐—ป & ๐˜๐—ฎ๐—น๐—น ๐—ฅ ๐—ถ๐—ป ๐—ฉ๐Ÿญ - ๐—ฉ๐Ÿฐ

121
Q

Cardiac Biomarkers and Blood investigation

A

๐—–๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ฎ๐—ฐ ๐—ฏ๐—ถ๐—ผ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐—ฟ

๐Ÿ”น Unstable angina : No detectable โ†‘ in troponin

๐Ÿ”น MI : โ†‘ In troponin T,I & other cardiac enzymes

*** Troponins T & I

+ ๐—œ๐—ป๐—ฐ๐—ฟ๐—ฒ๐—ฎ๐˜€๐—ฒ ๐˜„๐—ถ๐˜๐—ต๐—ถ๐—ป ๐Ÿฏโ€“๐Ÿฒ ๐—ต๐—ผ๐˜‚๐—ฟ๐˜€

+ ๐—ฃ๐—ฒ๐—ฎ๐—ธ ๐—ฎ๐˜ ๐—ฎ๐—ฏ๐—ผ๐˜‚๐˜ ๐Ÿฏ๐Ÿฒ ๐—ต๐—ผ๐˜‚๐—ฟ๐˜€

+ ๐—ฅ๐—ฒ๐—บ๐—ฎ๐—ถ๐—ป ๐—ฒ๐—น๐—ฒ๐˜ƒ๐—ฎ๐˜๐—ฒ๐—ฑ ๐—ณ๐—ผ๐—ฟ ๐˜‚๐—ฝ ๐˜๐—ผ ๐Ÿฎ ๐˜„๐—ฒ๐—ฒ๐—ธ๐˜€.

โ™ฆ๏ธ โ†‘ WBC,CRP & ESR

โ™ฆ๏ธ Lipids should be measured within 24 hr as there is often a transient fall in cholesterol in the 3 months following infarction

122
Q

๐—–๐—ผ๐—ฟ๐—ผ๐—ป๐—ฎ๐—ฟ๐˜† ๐—ฎ๐—ฟ๐˜๐—ฒ๐—ฟ๐—ถ๐—ผ๐—ด๐—ฟ๐—ฎ๐—ฝ๐—ต๐˜† / Angiography Indication

A

+ ๐—ฎ๐—น๐—น ๐—ฝ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜๐˜€ ๐—ฎ๐˜ ๐—บ๐—ผ๐—ฑ๐—ฒ๐—ฟ๐—ฎ๐˜๐—ฒ ๐—ผ๐—ฟ ๐—ต๐—ถ๐—ด๐—ต ๐—ฟ๐—ถ๐˜€๐—ธ ๐—ผ๐—ณ ๐—ฎ ๐—ณ๐˜‚๐—ฟ๐˜๐—ต๐—ฒ๐—ฟ ๐—ฒ๐˜ƒ๐—ฒ๐—ป๐˜

+ ๐—ช๐—ต๐—ผ ๐—ณ๐—ฎ๐—ถ๐—น ๐˜๐—ผ ๐˜€๐—ฒ๐˜๐˜๐—น๐—ฒ ๐—ผ๐—ป ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ฎ๐—น ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜†

+ ๐—ช๐—ถ๐˜๐—ต ๐—ฒ๐˜…๐˜๐—ฒ๐—ป๐˜€๐—ถ๐˜ƒ๐—ฒ ๐—˜๐—–๐—š ๐—ฐ๐—ต๐—ฎ๐—ป๐—ด๐—ฒ๐˜€

+ ๐—ช๐—ถ๐˜๐—ต ๐—ฎ๐—ป ๐—ฒ๐—น๐—ฒ๐˜ƒ๐—ฎ๐˜๐—ฒ๐—ฑ ๐—ฐ๐—ฎ๐—ฟ๐—ฑ๐—ถ๐—ฎ๐—ฐ ๐˜๐—ฟ๐—ผ๐—ฝ๐—ผ๐—ป๐—ถ๐—ป

+ ๐—ช๐—ถ๐˜๐—ต ๐˜€๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐—ฒ ๐—ฝ๐—ฟ๐—ฒ-๐—ฒ๐˜…๐—ถ๐˜€๐˜๐—ถ๐—ป๐—ด ๐˜€๐˜๐—ฎ๐—ฏ๐—น๐—ฒ ๐—ฎ๐—ป๐—ด๐—ถ๐—ป๐—ฎ